Press Release and Community Statement: Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia
Industry News
Blog|Jul 7 2025
Meet the Community: Megan Ploch
Community
News|Jul 3 2025
June/July 2025 – Advocacy Newsletter
Advocacy
News|Jun 30 2025
Press Release: Muscular Dystrophy Association and Friedreich’s Ataxia Research Alliance Announce New Collaborative Grant to Study Cardiac Fibrosis in Friedreich’s Ataxia